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The bacterium Burkholderia pseudomallei causes the disease melioidosis, a 
significant public health threat in endemic regions and is a potential 
biowarfare agent. Treatment of melioidosis is intensive and prolonged and 
there is no licensed vaccine to protect against it. The aim of this study was to 
characterise novel targets for antimicrobials to improve treatment of 
melioidosis. 
 
A holistic down selection process was undertaken in order to identify a range 
of possible novel and exploitable antimicrobial targets in Burkholderia 
pseudomallei. Four targets: FtsA, FtsZ, MraW and TonB  were selected for 
characterisation by mutagenesis study.  
 
FtsA and FtsZ are early effectors of cell division and are considered potential 
antimicrobial drug targets in other pathogenic bacteria. Genes for both were 
shown likely to be essential for viability in Burkholderia pseudomallei, 
following attempted deletion of the genes, thus confirming their potential for 
drug targeting for treatment of melioidosis.  
 
MraW, a highly conserved methyltransferase, and TonB, the energiser for 
high affinity iron uptake in Gram negative bacteria, were also selected for 
characterisation as antimicrobial targets. In-frame deletions of the genes 
encoding these targets were constructed in B. pseudomallei K96243. In order 
to determine the roles played by MraW and TonB during infection, these 




 Deletion of mraW rendered the bacteria non-motile and led to attenuation 
during infection of Balb/C mice. A small growth defect was seen early during 
infection of macrophages by this mutant, whilst no attenuation was seen on 
deletion of mraW in Galleria mellonella. Burkholderia pseudomallei ΔtonB 
required free iron supplementation for growth. This mutant had an improved 
ability to invade murine macrophages, though the mutant was attenuated in 
both Galleria mellonella and Balb/C mice.  
 
Attenuation of both mutants in a mammalian model of infection, support the 
strategy to target either of these proteins as novel targets for inhibition with 
small molecules during Burkholderia pseudomallei infection. However, an 
improved ability to infect macrophages by Burkholderia pseudomallei ΔtonB 
and non-complementation of this mutant by iron supplementation to Galleria 
mellonella suggests additional roles to iron uptake alone for TonB in 
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